Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Classical hematology 1

Conditions

Rare Diseases 1Pancreatic Neoplasms 1Gastrointestinal Diseases 1Crohn Disease 1Cachexia 1Anorexia 1Anemia 1

Interventions

Blood Specimen Collection 3Standard of Care 2Diet Therapy 2telotristat ethyl 1remune 1ostarine 1nabiximols 1irinotecan sucrosofate 1dermcidin 1bermekimab 1anamorelin 1Resistance Training 1Powders 1Omacor 1Olanzapine 1Nutritional Status 1Melatonin 1Megestrol Acetate 1Infliximab 1Immunologic Techniques 1Ibuprofen 1Gemcitabine 1Fluorouracil 1Exercise 1Enteral Nutrition 1Cyproheptadine 1Curcumin 1Calorimetry, Indirect 1Calorimetry 1Body Height 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cachexia × Infliximab × Gastrointestinal × Clear all
NCT00060502 2011-05-17

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia

Centocor, Inc.

Phase 2 Completed
73 enrolled
Classical hematologyGastrointestinal

Anemia, Anorexia, Cachexia, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡